Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: Factors influencing on international application of evidence-based guidelines

2007 ◽  
Vol 118 (1) ◽  
pp. 88-96 ◽  
Author(s):  
Yasuaki Hayashino ◽  
Takuro Shimbo ◽  
Satoru Tsujii ◽  
Hitoshi Ishii ◽  
Hirokazu Kondo ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Evidence Based ◽  
Factors Influencing ◽  
Asymptomatic Patients ◽  
Artery Disease ◽  
Evidence Based Guidelines

scholarly journals Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with type 2 diabetes and additional atherogenic risk factors

2004 ◽  
Vol 19 (12) ◽  
pp. 1181-1191 ◽  
Author(s):  
Yasuaki Hayashino ◽  
Sizuko Nagata-Kobayashi ◽  
Takeshi Morimoto ◽  
Kenji Maeda ◽  
Takuro Shimbo ◽  
...  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Coronary Artery Disease ◽  
Cost Effectiveness ◽  
Coronary Artery ◽  
Asymptomatic Patients ◽  
Artery Disease

scholarly journals Silent coronary artery disease in type 2 diabetes: a narrative review on epidemiology, risk factors, and clinical studies

2021 ◽  
Author(s):  
Saula Vigili de Kreutzenberg
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Point Of View ◽  
Narrative Review ◽  
Silent Coronary Artery Disease ◽  
Artery Disease ◽  
Associated Risk Factors

Silent coronary artery disease (CAD) is one of the manifestations of heart disease that particularly affects subjects with type 2 diabetes mellitus (T2DM). From a clinical point of view, silent CAD represents a constant challenge for the diabetologist, who has to decide whether a patient could or could not be screened for this disease. In the present narrative review, several aspects of silent CAD are considered: the epidemiology of the disease, the associated risk factors, and main studies conducted, in the last 20 years, especially aimed to demonstrate the usefulness of the screening of silent CAD, to improve cardiovascular outcomes in type 2 diabetes.

Sign in / Sign up

Export Citation Format

Share Document